142 related articles for article (PubMed ID: 28608357)
1. [Posterior reversible encephalopathy syndrome associated to chemotherapy. Gemcitabine as the causative agent].
Sanchez-Cendra C; Malon-Gimenez D; Guerra-Martinez JA; Calzas-Rodriguez J; Anton-Pascual B; Olmo-Sanchez A
Rev Neurol; 2017 Jun; 64(12):574-575. PubMed ID: 28608357
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.
Cioffi P; Laudadio L; Nuzzo A; Belfiglio M; Petrelli F; Grappasonni I
J Oncol Pharm Pract; 2012 Jun; 18(2):299-302. PubMed ID: 22065198
[TBL] [Abstract][Full Text] [Related]
3. Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome.
Schaub JR; Tang SC
Am J Med Sci; 2021 Jun; 361(6):795-798. PubMed ID: 33888263
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.
Rajasekhar A; George TJ
Oncologist; 2007 Nov; 12(11):1332-5. PubMed ID: 18055853
[TBL] [Abstract][Full Text] [Related]
5. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.
Cherniawsky H; Merchant N; Sawyer M; Ho M
Medicine (Baltimore); 2017 Feb; 96(8):e5850. PubMed ID: 28225482
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
Han CH; Findlay MP
Intern Med J; 2010 Feb; 40(2):153-9. PubMed ID: 20446957
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.
Patel A; Ayto R; MacDonald DH
Br J Haematol; 2013 Jun; 161(5):607. PubMed ID: 23617825
[No Abstract] [Full Text] [Related]
8. Chemotherapy-related posterior reversible leukoencephalopathy syndrome.
Bhatt A; Farooq MU; Majid A; Kassab M
Nat Clin Pract Neurol; 2009 Mar; 5(3):163-9. PubMed ID: 19262592
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome after high-dose cytarabine in acute myelogenous leukemia.
Newey CR; Chandrasekaran PN; Mohebbi MR
Neurol India; 2017; 65(1):220. PubMed ID: 28084289
[No Abstract] [Full Text] [Related]
10. Veno-occlusive disease of the liver induced by gemcitabine.
Dobbie M; Hofer S; Oberholzer M; Herrmann R
Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
[No Abstract] [Full Text] [Related]
11. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine.
Castellano D; Hitt R; Cortés-Funes H; Romero A; Rodriguez-Peralto JL
J Clin Oncol; 2000 Feb; 18(3):695-6. PubMed ID: 10653886
[No Abstract] [Full Text] [Related]
12. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.
Maeda T; Kikuchi E; Matsumoto K; Yazawa S; Hagiuda J; Miyajima A; Nakagawa K; Fujiwara H; Hoshino H; Oya M
Int J Clin Oncol; 2010 Oct; 15(5):508-11. PubMed ID: 20352464
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
14. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
Chang Y; Mbeo G; Littman SJ
J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
[TBL] [Abstract][Full Text] [Related]
15. Anal pruritus after cancer chemotherapy with gemcitabine.
Hejna M; Valencak J; Raderer M
N Engl J Med; 1999 Feb; 340(8):655-6. PubMed ID: 10049089
[No Abstract] [Full Text] [Related]
16. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
[No Abstract] [Full Text] [Related]
17. Gemcitabine-induced thrombotic microangiopathy.
Richmond J; Gilbar P; Abro E
Intern Med J; 2013 Nov; 43(11):1240-2. PubMed ID: 24237646
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings.
Russell MT; Nassif AS; Cacayorin ED; Awwad E; Perman W; Dunphy F
Magn Reson Imaging; 2001 Jan; 19(1):129-32. PubMed ID: 11295355
[TBL] [Abstract][Full Text] [Related]
19. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
Wiznia LE; Subtil A; Choi JN
JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine and haemolytic-uraemic syndrome.
Ruiz I; Del Valle J; Gómez A
Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
